- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.03. | Lucid Group appoints former Pfizer R&D leader Rod MacKenzie as Board Chair | ||
| 18.03. | Atrogi moves forward in phase 1 trial for oral candidate to improve metabolic and muscle health | ||
| 18.03. | Sandoz appoints Armin Metzger as President of new global unit | ||
| 17.03. | WHO releases new target product profiles for urgently needed antibiotics | ||
| 17.03. | BioDuro appoints Andrew Thomas and Stevan Djuric as Scientific Advisors | ||
| 16.03. | AstraZeneca's Imfinzi approved in EU for early gastric and gastro-oesophageal cancers | ||
| 16.03. | Odyssey Therapeutics appoints H Martin Seidel to Scientific Advisory Board | ||
| 13.03. | MHRA approves Leqselvi for severe alopecia areata | ||
| 13.03. | Athlone Laboratories hosts ministerial visit to discuss the future of critical medicines in Ireland | ||
| 12.03. | Bristol Myers Squibb's Sotyktu approved by US FDA for psoriatic arthritis | ||
| 12.03. | Inizio Ignite announces key leadership appointments | ||
| 11.03. | Incyte's Opzelura approved by NICE for patients with non-segmental vitiligo on the NHS | ||
| 11.03. | Commit Biologics appoints Thomas Montgomery Andresen as CEO | ||
| 10.03. | Lundbeck completes patient randomisation for phase 3 trial for multiple system atrophy treatment | ||
| 10.03. | Business as usual? Patient-centricity in the age of AI | ||
| 10.03. | Novo Nordisk elects employee representatives to Board of Directors | ||
| 09.03. | How HCP Interact is advancing Medical Affairs performance with AI-enabled precision | ||
| 09.03. | Johnson & Johnson's multiple myeloma treatment approved by US FDA | ||
| 06.03. | How STEM AI helps organisations understand and improve HCP interactions at scale | ||
| 06.03. | Gilead Foundation announces $12m investment through HIV Prevention Initiative | ||
| 05.03. | AI is quietly rewriting your brand narrative | ||
| 05.03. | GenAI: embracing the transformation - with caution | ||
| 05.03. | CNX Therapeutics appoints Erin Federman as non-executive director | ||
| 04.03. | J&J's nipocalimab gets FDA Fast Track designation for lupus | ||
| 03.03. | emc3 Collective launches human-centred healthcare events brand |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.